Otsuka Holdings Co., Ltd. (4578)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Otsuka Holdings Co., Ltd. (4578)
Go deeper and ask any question about 4578
Company Performance
Current Price
as of Sep 17, 2024$57.22
P/E Ratio
34.42
Market Cap
$30.77B
Description
Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. It operates through the following segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
Metrics
Overview
- HQTokyo, TY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker4578
- Price$57.216431+0.34%
Trading Information
- Market Cap$30.77B
- Float75.71%
- Average Daily Volume (1m)1,184,819
- Average Daily Volume (3m)1,510,926
- EPS$233.68
Company
- Revenue$2.18T
- Rev Growth (1yr)18.07%
- Net Income$30.42B
- Gross Margin72.11%
- EBITDA Margin23.89%
- EBITDA$140.81B
- EV$3.48T
- EV/Revenue1.60
- P/E34.42
- P/S2.00